TechNavio's analysts forecast the Global DNA Sequencing Products market to grow at a CAGR of 18.48 percent over the period 2012-2016. One of the key factors contributing to this market growth is the introduction of whole genome sequencing. The Global DNA Sequencing Products market has also been witnessing an increase in the number of DNA sequencing projects. However, the low adoption of genomic technology could pose a challenge to the growth of this market.
TechNavio's report, the Global DNA Sequencing Products Market 2012-2016, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global DNA Sequencing Products market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Agilent Technologies Inc., Hoffmann-La Roche Ltd., Illumina Inc., and Pacific Biosciences of California Inc.
The other vendors mentioned in the report are Genia Corp., International Business Machines Corp., Knome Inc., Life Technologies Corp., Oxford Nanopore Technologies Ltd., and RainDance Technologies Inc.
Key questions answered in this report:
Make an enquiry before buying this Report
Please fill the enquiry form below.
Endobronchial cancer are characterized by small size, slow growth and usually misdiagnosed as asthma or chronic bronchitis due to their common symptoms. These cancers are usually benign and rare. Due to these reasons, they may remain undiagnosed for a long time and lead to serious complications. The term bronchial adenoma encompasses a diverse group of tumors of mucous glands, trachea or bronchi. Common symptoms of endobronchial cancer include ...
Single-stranded fragments of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) are called DNA probes and RNA probes respectively.These DNA and RNA probes are short in length (usually 100-1000 bases long) capable of forming highly specific, non-covalent duplexes with complementary sequence of nucleic acid strand. Therefore typical applications of these probes are in (fluorescence) in situ hybridization ((F)ISH), microarray-based gene ...
Multiple myeloma is a form of plasma cancer that develops in the bone marrow. It is the second most prevalent blood cancer type in the U.S. In 2011, the global multiple myeloma drugs market was calculated at USD 3.2 billion. The market will be driven by factors such as rising incidences of plasma cancer, and lifestyle habits. Increasing market penetration of cancer drugs, especially Revlimid, and their combination with emerging therapies wi...